back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2023-10-24 14:58 Tx date 2023-10-23 |
$DMT
Small Pharma Inc. (formerly, Unilock Capital Corp.) |
Cybin Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
336,012,037 | ||
| Filed 2023-10-23 20:16 Tx date 2023-10-23 |
$DMT
Small Pharma Inc. (formerly, Unilock Capital Corp.) |
Tziras, George
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
|
-5,374,627 vol |
0 | |
| Filed 2023-10-23 20:14 Tx date 2023-10-23 |
$DMT
Small Pharma Inc. (formerly, Unilock Capital Corp.) |
Tziras, George
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
|
-2,200,000 vol |
0 | |
| Filed 2023-10-23 20:11 Tx date 2023-10-23 |
$DMT
Small Pharma Inc. (formerly, Unilock Capital Corp.) |
Wolfe, Michael Andrew
4 - Director of Issuer
Direct Ownership
|
Common Shares
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
|
-100,000 vol |
0 | |
| Filed 2023-10-23 20:10 Tx date 2023-10-23 |
$DMT
Small Pharma Inc. (formerly, Unilock Capital Corp.) |
Wolfe, Michael Andrew
4 - Director of Issuer
Direct Ownership
|
Options
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
|
-270,000 vol |
0 | |
| Filed 2023-10-23 20:06 Tx date 2023-10-23 |
$DMT
Small Pharma Inc. (formerly, Unilock Capital Corp.) |
Steel, David
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
|
-94,785 vol |
0 | |
| Filed 2023-10-23 20:05 Tx date 2023-10-23 |
$DMT
Small Pharma Inc. (formerly, Unilock Capital Corp.) |
Steel, David
5 - Senior Officer of Issuer
Direct Ownership
|
Options
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
|
-1,850,000 vol |
0 | |
| Filed 2023-10-23 20:01 Tx date 2023-10-23 |
$DMT
Small Pharma Inc. (formerly, Unilock Capital Corp.) |
Fortin, Lyne
4 - Director of Issuer
Direct Ownership
|
Common Shares
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
|
-200,000 vol |
0 | |
| Filed 2023-10-23 19:56 Tx date 2023-10-23 |
$DMT
Small Pharma Inc. (formerly, Unilock Capital Corp.) |
Layzell, Marie
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
|
-5,782,600 vol |
0 | |
| Filed 2023-10-23 19:52 Tx date 2023-10-23 |
$DMT
Small Pharma Inc. (formerly, Unilock Capital Corp.) |
Maier, Paul Victor
4 - Director of Issuer
Direct Ownership
|
Options
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
|
-180,000 vol |
0 | |
| Filed 2023-10-23 19:44 Tx date 2023-10-23 |
$DMT
Small Pharma Inc. (formerly, Unilock Capital Corp.) |
Rands, Peter David
3 - 10% Security Holder of Issuer
Holder: Spouse (Indirect Ownership)
|
Common Shares
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
|
-9,103,450 vol |
0 | |
| Filed 2023-10-23 19:43 Tx date 2023-10-23 |
$DMT
Small Pharma Inc. (formerly, Unilock Capital Corp.) |
Rands, Peter David
3 - 10% Security Holder of Issuer
Holder: Family Trust (Indirect Ownership)
|
Common Shares
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
|
-466,441 vol |
0 | |
| Filed 2023-10-23 19:42 Tx date 2023-10-23 |
$DMT
Small Pharma Inc. (formerly, Unilock Capital Corp.) |
Rands, Peter David
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
|
-72,202,133 vol |
0 | |
| Filed 2023-10-23 19:34 Tx date 2023-10-23 |
$DMT
Small Pharma Inc. (formerly, Unilock Capital Corp.) |
Routledge, Carol
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
|
-5,300,000 vol |
0 | |
| Filed 2023-10-23 13:23 Tx date 2023-10-23 |
$DMT
Small Pharma Inc. (formerly, Unilock Capital Corp.) |
Tziras, George
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$12,424
+118,327 vol $0.105 each |
5,374,627 | |
| Filed 2023-10-23 13:19 Tx date 2023-10-23 |
$DMT
Small Pharma Inc. (formerly, Unilock Capital Corp.) |
Tziras, George
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
-875,000 vol |
2,200,000 | |
| Filed 2023-10-23 13:15 Tx date 2023-10-18 |
$DMT
Small Pharma Inc. (formerly, Unilock Capital Corp.) |
Tziras, George
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$13,125
+125,000 vol $0.105 each |
5,256,300 | |
| Filed 2023-10-23 13:11 Tx date 2023-10-18 |
$DMT
Small Pharma Inc. (formerly, Unilock Capital Corp.) |
Tziras, George
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
-125,000 vol |
3,075,000 | |
| Filed 2023-10-02 18:06 Tx date 2023-09-29 |
$DMT
Small Pharma Inc. (formerly, Unilock Capital Corp.) |
Rands, Peter David
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-21,460
-145,000 vol $0.148 each |
73,618,132 | |
| Filed 2023-10-02 18:05 Tx date 2023-09-28 |
$DMT
Small Pharma Inc. (formerly, Unilock Capital Corp.) |
Rands, Peter David
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-59,826.48
-417,200 vol $0.1434 each |
73,763,132 |